NEW YORK, April 24, 2024 /PRNewswire/ Synaptogenix, Inc. , an emerging biopharmaceutical company developing therapeutics for neurodegenerative disorders, today announced that it received notice.
Synaptogenix Increases Stake in Innovative Psilocybin Drug Discovery Company through its Partnership with Cannasoul Analytics lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.
Synaptogenix Announces Reverse Stock Split to Maintain Nasdaq Listing lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.